Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01588730 · ClinicalTrials.gov registry record · Phase 4
Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy
A Phase 4 study, sponsored by Dynasplint Systems.
- Terminated
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT01588730: Clinical Trial Phase 4 study, sponsored by Dynasplint Systems.
NCT01588730 is a Phase 4 study that was terminated before completion, run by Dynasplint Systems. The registered enrollment target is 26 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01588730, a Phase 4 study, was terminated before completion, sponsored by Dynasplint Systems.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the Ankle Dorsiflexion Dynasplint System (DS) to static night splint for the reduction of pain from Plantar Fasciitis (Fasciopathy).
Primary Outcome
The primary outcome measure will be difference between the pretreatment and two month cumulative Foot Function Index (PS-FFI) score
Interventions
- DEVICE Ankle Dorsiflexion Dynasplint
- PROCEDURE Commercially Available Static Night splint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-06 |
| Phase | Phase 4 |
Why NCT01588730 stopped before completion
NCT01588730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Ankle Dorsiflexion Dynasplint is the first listed.
NCT01588730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01588730 about?
NCT01588730 is a clinical study titled "Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy". The purpose of this study is to compare the Ankle Dorsiflexion Dynasplint System (DS) to static night splint for the reduction of pain from Plantar Fasciitis (Fasciopathy).
What is the current status of trial NCT01588730?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2011-06.
What interventions are being tested in trial NCT01588730?
The interventions under investigation include: Ankle Dorsiflexion Dynasplint (DEVICE), Commercially Available Static Night splint (PROCEDURE).
Who is sponsoring clinical trial NCT01588730?
This trial is sponsored by Dynasplint Systems, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01588730's enrollment target sits among peer trials
26 1655th of 2000 higher than 332 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia